Literature DB >> 23142484

Estrogen defines the dynamics and destination of transactivated EGF receptor in breast cancer cells: role of S1P₃ receptor and Cdc42.

O Sukocheva1, C Wadham, P Xia.   

Abstract

Sphingosine-1-phosphate (S1P) receptors mediate transactivation of epidermal growth factor receptor (EGFR) by estrogen (E2). Here we report that the amount of intracellular EGFR remains elevated after stimulation of MCF-7 cells with E2 and S1P, although membrane-localized EGFR and S1P3 receptors are quickly internalized. Co-localization of internalized EGFR and LAMP-2 was lower in cells treated with E2/S1P, suggesting that endosomal EGFR might be directed for recycling instead of degradation. In addition, we found that E2/S1P activated Cdc42 and that knockdown of Cdc42 restores fast EGFR degradation after E2/S1P stimulation. Inhibition of S1P3 receptors prevented E2-induced activation of Cdc42, supporting the important role of the S1P receptor in E2 signaling. This is a novel mechanism further defining the effect of E2/S1P on the EGFR transactivation in breast cancer cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142484     DOI: 10.1016/j.yexcr.2012.10.014

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

Review 1.  An update on the biology of sphingosine 1-phosphate receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  J Lipid Res       Date:  2014-01-23       Impact factor: 5.922

Review 2.  Lysophospholipid receptor nomenclature review: IUPHAR Review 8.

Authors:  Yasuyuki Kihara; Michael Maceyka; Sarah Spiegel; Jerold Chun
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

3.  Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer.

Authors:  Melissa A Maczis; Michael Maceyka; Michael R Waters; Jason Newton; Manjulata Singh; Madisyn F Rigsby; Tia H Turner; Mohammad A Alzubi; J Chuck Harrell; Sheldon Milstien; Sarah Spiegel
Journal:  J Lipid Res       Date:  2018-10-12       Impact factor: 5.922

4.  Role of Sphingosine Kinase 1 and S1P Transporter Spns2 in HGF-mediated Lamellipodia Formation in Lung Endothelium.

Authors:  Panfeng Fu; David L Ebenezer; Evgeny V Berdyshev; Irina A Bronova; Mark Shaaya; Anantha Harijith; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2016-11-18       Impact factor: 5.157

5.  Sphingosine kinase (SphK) 1 and SphK2 play equivalent roles in mediating insulin's mitogenic action.

Authors:  Lan Dai; Yanfei Qi; Jinbiao Chen; Dominik Kaczorowski; Wen Di; Wei Wang; Pu Xia
Journal:  Mol Endocrinol       Date:  2013-01-01

6.  Systemic distribution, subcellular localization and differential expression of sphingosine-1-phosphate receptors in benign and malignant human tissues.

Authors:  Chunyi Wang; Jinghe Mao; Samantha Redfield; Yinyuan Mo; Janice M Lage; Xinchun Zhou
Journal:  Exp Mol Pathol       Date:  2014-07-30       Impact factor: 3.362

Review 7.  Sphingosine kinase 1 in breast cancer.

Authors:  Kurt Geffken; Sarah Spiegel
Journal:  Adv Biol Regul       Date:  2017-10-16

8.  Divergence of Intracellular Trafficking of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Receptor 3 in MCF-7 Breast Cancer Cells and MCF-7-Derived Stem Cell-Enriched Mammospheres.

Authors:  Olga A Sukocheva; Dong Gui Hu; Robyn Meech; Anupam Bishayee
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

9.  SPHK1 regulates proliferation and survival responses in triple-negative breast cancer.

Authors:  Arpita Datta; Ser Yue Loo; Baohua Huang; Lingkai Wong; Sheryl S L Tan; Tuan Zea Tan; Soo-Chin Lee; Jean Paul Thiery; Yaw Chyn Lim; Wei Peng Yong; Yulin Lam; Alan Prem Kumar; Celestial T Yap
Journal:  Oncotarget       Date:  2014-08-15

Review 10.  Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research.

Authors:  Zhixiang Wang
Journal:  Int J Mol Sci       Date:  2016-01-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.